Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

AVITA Medical (RCEL) stock in plain English

Free brief · no signupStart here
RCELPublished Nov 18, 2026
AVITA Medical Inc
Healthcare · Medical Devices
Manufactures single-use medical kits that prepare regenerative skin cell suspensions directly in hospital operating rooms.
Assets:
RECELL platformproprietary autologous cell harvesting device line for thermal burns and vitiligo
Valencia facilityintegrated manufacturing, research, and corporate headquarters site in California
RECELL GOautomated point-of-care cellular suspension processing device approved by regulators
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

49
OPS ScoreOperating finances
Latest quote
-4.99%$15.99
$397.19M
n/a (loss)
$84.69M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 18, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was RCEL. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does AVITA Medical (RCEL) do?

AVITA Medical Inc (RCEL) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures single-use medical kits that prepare regenerative skin cell suspensions directly in hospital operating rooms. It uses a point-of-care medical device to prepare sprayable autologous skin cells from a small patient biopsy. It is worth $397.19M on the market and sold $84.69M over the last year.

Market cap
$397.19M
P/E ratio
None (reported a loss)
Annual sales
$84.69M
Sector
Healthcare
Industry
Medical Devices
Brief updated
Nov 18, 2026

Brands and businesses behind RCEL

  • RECELL: Sells single-use devices that process patient skin biopsies into sprayable regenerative cell suspensions for wound healing.
  • RECELL GO: Provides automated enzyme-based skin cell processing hardware and cartridges to hospitals treating severe wounds.

RCEL’s flags, in plain English

Each flag is a number from AVITA Medical’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 18, 2026.

Wide Gross Margin

Gross margin of 82.4% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Still Climbing

Sales up 38.1% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Burning Cash

Losing money, profit margin of -42.7%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.

2 more risk notes open with the free trial. Try it free for 7 days.

Questions about RCEL

How big is AVITA Medical?

AVITA Medical’s market cap is $397.19M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $84.69M: what customers paid the company over the last year, before any costs.

What is RCEL’s P/E ratio?

RCEL has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with RCEL?

Revenue depends almost entirely on the commercial adoption of the RECELL product line in a small number of specialized burn centers. That is one risk on AVITA Medical’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From AVITA Medical’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. RCEL’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card